[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@BlaseBio](/creator/twitter/BlaseBio)
"EcoR1 reports a XXX% stage in Galapagos NV $GLPG The Reporting Persons intend to communicate with the BOD about the Issuers performance business operations strategic opportunities and governance including Board composition"  
[X Link](https://x.com/BlaseBio/status/1827075895506694628) [@BlaseBio](/creator/x/BlaseBio) 2024-08-23T20:10Z XXX followers, 25.9K engagements


"$EYPT Phase X for DME announced (2 NI trials 52/56w blended BCVA endpoint). Continued execution here. Will be very quick enrollment (they all are). This makes more sense than the $OCUL NPDR trial to me. Big market. BUT $OCUL has fancy new branding"  
[X Link](https://x.com/BlaseBio/status/1978191942987972676) [@BlaseBio](/creator/x/BlaseBio) 2025-10-14T20:11Z XXX followers, 3289 engagements


"Some interesting details in the $VSTM GFH375/VS-7375 data published by GenFleet (thanks @bigpharmaguy for sharing) Solid 2L response rates and PFS (huge asterix with small N). Most responses are confirmed. Genfleet notes that initial US AE data is better than Chinese"  
[X Link](https://x.com/BlaseBio/status/1982837145816764455) [@BlaseBio](/creator/x/BlaseBio) 2025-10-27T15:49Z XXX followers, 3177 engagements